Financials
- Market Capitalization 2.08 B
- Employee 398
- Founded 1989
- CEO Nick Colangelo
- Website www.vcel.com
- Headquarter Michigan, United States
- FIGI BBG000BDCM24
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
112.53
Rapporto prezzo/fatturato
6.8
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 1921 | VRDN Viridian Therapeutics, Inc. - Common Stock | 18.30 USD | -1.93% | -3.84% | -14.76% | -18.49% | 2.07 B USD | ||
| 1927 | NVAX Novavax, Inc. - Common Stock | 12.66 USD | -0.71% | +0.80% | +34.39% | +50.36% | 2.09 B USD | ||
| 1944 | VERA Vera Therapeutics, Inc. - Class A Common Stock | 27.75 USD | -7.13% | -7.04% | -20.96% | -6.69% | 2.00 B USD | ||
| 1950 | PHVS Pharvaris N.V. - Ordinary Shares | 30.86 USD | -0.77% | +1.21% | -19.32% | +38.63% | 2.01 B USD |